Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing for intraoperative wake-up test in scoliosis surgery
ChiCTR2100049341Phase 4Completed
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in scoliosis (3 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoints: wake-up time and wake-up quality. Started Jan 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
scoliosis
Beyond the preview
Go deeper on ChiCTR2100049341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049341.